Yüklüyor......

Cabergoline therapy for Macroprolactinoma during pregnancy: A case report

BACKGROUND: We assessed the safety of Cabergoline therapy during pregnancy in a lady with hyperprolactinemia intolerant to Bromocriptine. CASE PRESENTATION: We report the case of a 31 year old lady who presented to us with uncontrolled hyperprolactinemia. A pituitary Macroadenoma was demonstrated by...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Shahzad, Hira, Sheikh, Aisha, Sheikh, Lumaan
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: BioMed Central 2012
Konular:
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC3575245/
https://ncbi.nlm.nih.gov/pubmed/23110890
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1756-0500-5-606
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!